Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares IssuedShares Outstanding
Ratios

Harmony Biosciences Holdings (HRMY) Long-Term Debt Repayments: 2022-2025

Historic Long-Term Debt Repayments for Harmony Biosciences Holdings (HRMY) over the last 4 years, with Sep 2025 value amounting to $3.8 million.

  • Harmony Biosciences Holdings' Long-Term Debt Repayments changed negligibly% to $3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.0 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $15.0 million for FY2024, which is 215.79% up from last year.
  • As of Q3 2025, Harmony Biosciences Holdings' Long-Term Debt Repayments stood at $3.8 million, which was down 0.00% from $3.8 million recorded in Q2 2025.
  • In the past 5 years, Harmony Biosciences Holdings' Long-Term Debt Repayments registered a high of $3.8 million during Q4 2023, and its lowest value of $500,000 during Q1 2022.
  • Over the past 3 years, Harmony Biosciences Holdings' median Long-Term Debt Repayments value was $3.8 million (recorded in 2025), while the average stood at $3.1 million.
  • Data for Harmony Biosciences Holdings' Long-Term Debt Repayments shows a peak YoY soared of 650.00% (in 2023) over the last 5 years.
  • Over the past 4 years, Harmony Biosciences Holdings' Long-Term Debt Repayments (Quarterly) stood at $500,000 in 2022, then spiked by 650.00% to $3.8 million in 2023, then remained steady at $3.8 million in 2024, then remained steady at $3.8 million in 2025.
  • Its last three reported values are $3.8 million in Q3 2025, $3.8 million for Q2 2025, and $3.8 million during Q1 2025.